Details
Original language | English |
---|---|
Pages (from-to) | 327-336 |
Number of pages | 10 |
Journal | Journal of controlled release |
Volume | 294 |
Early online date | 23 Dec 2018 |
Publication status | Published - 28 Jan 2019 |
Abstract
Targeted delivery of drugs is a major challenge in treatment of diverse diseases. Systemically administered drugs demand high doses and are accompanied by poor selectivity and side effects on non-target cells. Here, we introduce a new principle for targeted drug delivery. It is based on macrophages as transporters for nanoparticle-coupled drugs as well as controlled release of drugs by hyperthermia mediated disruption of the cargo cells and simultaneous deliberation of nanoparticle-linked drugs. Hyperthermia is induced by an alternating electromagnetic field (AMF) that induces heat from silica-coated superparamagnetic iron oxide nanoparticles (SPIONs). We show proof-of-principle of controlled release by the simultaneous disruption of the cargo cells and the controlled, AMF induced release of a toxin, which was covalently linked to silica-coated SPIONs via a thermo-sensitive linker. Cells that had not been loaded with SPIONs remain unaffected. Moreover, in a 3D co-culture model we demonstrate specific killing of associated tumour cells when employing a ratio as low as 1:40 (SPION-loaded macrophage: tumour cells). Overall, our results demonstrate that AMF induced drug release from macrophage-entrapped nanoparticles is tightly controlled and may be an attractive novel strategy for targeted drug release.
Keywords
- Cell based drug delivery, Controlled drug delivery, 3D tumour model, Hyperthermia, Macrophages, Magnetic silica nanoparticles, Cell Line, Nanoparticles/administration & dosage, Silicon Dioxide/administration & dosage, Coculture Techniques, Ferric Compounds/administration & dosage, Humans, Neoplasms/drug therapy, Drug Delivery Systems, Maytansine/administration & dosage, Animals, Magnetic Phenomena, Models, Biological, Hyperthermia, Induced, Drug Liberation, Mice, Delayed-Action Preparations/administration & dosage
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pharmaceutical Science
Sustainable Development Goals
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Journal of controlled release, Vol. 294, 28.01.2019, p. 327-336.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model
AU - Ullah, Sami
AU - Seidel, Katja
AU - Türkkan, Sibel
AU - Warwas, Dawid Peter
AU - Dubich, Tatyana
AU - Rohde, Manfred
AU - Hauser, Hansjörg
AU - Behrens, Peter
AU - Kirschning, Andreas
AU - Köster, Mario
AU - Wirth, Dagmar
N1 - Funding information: This work was supported by grants from Deutsche Forschungsgemeinschaft, Germany (DFG, WI2648/3-1 , BE1664/21-1 ), the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) as well as from the Biofabrication for NIFE initiative, which is financially supported by the ministry of Lower Saxony, Germany, and the Volkswagen Stiftung, Germany (BIOFABRICATION FOR NIFE: VWZN2860 ). Further support came from the Ministry of Science and Culture of Lower Saxony, Germany, (MWK; graduate program Hannover School of Nanotechnology hosted by the Laboratory of Nano and Quantum Engineering (LNQE), Leibniz University Hannover ). S.U. wishes to acknowledge the HZI graduate school and DAAD, Germany, for support. S. T. was also supported by the DAAD, Germany . We thank I. Schleicher for assistance in the electron microscopy studies. Further thanks go to the LNQE for the use of their TEM equipment. This work was supported by grants from Deutsche Forschungsgemeinschaft, Germany (DFG, WI2648/3-1, BE1664/21-1), the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) as well as from the Biofabrication for NIFE initiative, which is financially supported by the ministry of Lower Saxony, Germany, and the Volkswagen Stiftung, Germany (BIOFABRICATION FOR NIFE: VWZN2860). Further support came from the Ministry of Science and Culture of Lower Saxony, Germany, (MWK; graduate program Hannover School of Nanotechnology hosted by the Laboratory of Nano and Quantum Engineering (LNQE), Leibniz University Hannover). S.U. wishes to acknowledge the HZI graduate school and DAAD, Germany, for support. S. T. was also supported by the DAAD, Germany. We thank I. Schleicher for assistance in the electron microscopy studies. Further thanks go to the LNQE for the use of their TEM equipment.
PY - 2019/1/28
Y1 - 2019/1/28
N2 - Targeted delivery of drugs is a major challenge in treatment of diverse diseases. Systemically administered drugs demand high doses and are accompanied by poor selectivity and side effects on non-target cells. Here, we introduce a new principle for targeted drug delivery. It is based on macrophages as transporters for nanoparticle-coupled drugs as well as controlled release of drugs by hyperthermia mediated disruption of the cargo cells and simultaneous deliberation of nanoparticle-linked drugs. Hyperthermia is induced by an alternating electromagnetic field (AMF) that induces heat from silica-coated superparamagnetic iron oxide nanoparticles (SPIONs). We show proof-of-principle of controlled release by the simultaneous disruption of the cargo cells and the controlled, AMF induced release of a toxin, which was covalently linked to silica-coated SPIONs via a thermo-sensitive linker. Cells that had not been loaded with SPIONs remain unaffected. Moreover, in a 3D co-culture model we demonstrate specific killing of associated tumour cells when employing a ratio as low as 1:40 (SPION-loaded macrophage: tumour cells). Overall, our results demonstrate that AMF induced drug release from macrophage-entrapped nanoparticles is tightly controlled and may be an attractive novel strategy for targeted drug release.
AB - Targeted delivery of drugs is a major challenge in treatment of diverse diseases. Systemically administered drugs demand high doses and are accompanied by poor selectivity and side effects on non-target cells. Here, we introduce a new principle for targeted drug delivery. It is based on macrophages as transporters for nanoparticle-coupled drugs as well as controlled release of drugs by hyperthermia mediated disruption of the cargo cells and simultaneous deliberation of nanoparticle-linked drugs. Hyperthermia is induced by an alternating electromagnetic field (AMF) that induces heat from silica-coated superparamagnetic iron oxide nanoparticles (SPIONs). We show proof-of-principle of controlled release by the simultaneous disruption of the cargo cells and the controlled, AMF induced release of a toxin, which was covalently linked to silica-coated SPIONs via a thermo-sensitive linker. Cells that had not been loaded with SPIONs remain unaffected. Moreover, in a 3D co-culture model we demonstrate specific killing of associated tumour cells when employing a ratio as low as 1:40 (SPION-loaded macrophage: tumour cells). Overall, our results demonstrate that AMF induced drug release from macrophage-entrapped nanoparticles is tightly controlled and may be an attractive novel strategy for targeted drug release.
KW - Cell based drug delivery
KW - Controlled drug delivery, 3D tumour model
KW - Hyperthermia
KW - Macrophages
KW - Magnetic silica nanoparticles
KW - Cell Line
KW - Nanoparticles/administration & dosage
KW - Silicon Dioxide/administration & dosage
KW - Coculture Techniques
KW - Ferric Compounds/administration & dosage
KW - Humans
KW - Neoplasms/drug therapy
KW - Drug Delivery Systems
KW - Maytansine/administration & dosage
KW - Animals
KW - Magnetic Phenomena
KW - Models, Biological
KW - Hyperthermia, Induced
KW - Drug Liberation
KW - Mice
KW - Delayed-Action Preparations/administration & dosage
UR - http://www.scopus.com/inward/record.url?scp=85059177725&partnerID=8YFLogxK
U2 - 10.1016/j.jconrel.2018.12.040
DO - 10.1016/j.jconrel.2018.12.040
M3 - Article
C2 - 30586597
AN - SCOPUS:85059177725
VL - 294
SP - 327
EP - 336
JO - Journal of controlled release
JF - Journal of controlled release
SN - 0168-3659
ER -